Target
Sodium/bile acid cotransporter
Ligand
BDBM400151
Substrate
n/a
Meas. Tech.
HBV DNA Quantification Assay
EC50
79.9±n/a nM
Citation
 Du, JKaplan, JAKirschberg, TAKobayashi, TLazerwith, SELee, RAMedley, JWMitchell, MLMorganelli, PAPyun, HShevick, SLSquires, NHWatkins, WJ Substituted pyrrolizine compounds and uses thereof US Patent  US10328053 Publication Date 6/25/2019 
Target
Name:
Sodium/bile acid cotransporter
Synonyms:
Bile acid transporter | NTCP | NTCP_HUMAN | SLC10A1
Type:
PROTEIN
Mol. Mass.:
38131.81
Organism:
Homo sapiens (Human)
Description:
ChEMBL_838517
Residue:
349
Sequence:
MEAHNASAPFNFTLPPNFGKRPTDLALSVILVFMLFFIMLSLGCTMEFSKIKAHLWKPKGLAIALVAQYGIMPLTAFVLGKVFRLKNIEALAILVCGCSPGGNLSNVFSLAMKGDMNLSIVMTTCSTFCALGMMPLLLYIYSRGIYDGDLKDKVPYKGIVISLVLVLIPCTIGIVLKSKRPQYMRYVIKGGMIIILLCSVAVTVLSAINVGKSIMFAMTPLLIATSSLMPFIGFLLGYVLSALFCLNGRCRRTVSMETGCQNVQLCSTILNVAFPPEVIGPLFFFPLLYMIFQLGEGLLLIAIFWCYEKFKTPKDKTKMIYTAATTEETIPGALGNGTYKGEDCSPCTA
  
Inhibitor
Name:
BDBM400151
Synonyms:
(R)-N-(3,4-difluorophenyl)-6-methyl-7-(2-oxo-2-((1,1,1-trifluoro-3-hydroxy-2-methylpropan-2-yl)amino)acetyl)-2,3-dihydro-1H-pyrrolizine-5-carboxamide | US10328053, Compound 135 | US10328053, Compound 136 | US10874640, Compound 136 | US20230270719, Compound 136
Type:
Small organic molecule
Emp. Form.:
C21H19F5N4O4
Mol. Mass.:
486.392
SMILES:
Cc1c(C(=O)C(=O)NC(C)(C(N)=O)C(F)(F)F)c2CCCn2c1C(=O)Nc1ccc(F)c(F)c1
Structure:
Search PDB for entries with ligand similarity: